4 ms·

I see discussion in this thread about what makes sense or seems reasonable, but no empirical observations. Two examples that come to my mind would be acetaminop

by arebop 12y ago

I see discussion in this thread about what makes sense or seems reasonable, but no empirical observations. Two examples that come to my mind would be acetaminophen and coral snake antivenin. The former is widely available as a generic, the latter is extremely scarce in the U.S. in part because its manufacturer fears competition. Maybe someone can add more examples or help explain the different outcomes for these two?

dragonwriter 12y ago
> Maybe someone can add more examples or help explain the different outcomes for these two? The different outcomes are largely explained thus: Drugs with a very large demand and especially ones which are OTC and around which consumer brands can be developed (where brand identity allows a premium to be charged, substituting in some degree for the monopoly rents patents allow) are likely to continue to be manufactured after patents expire. Prescription drugs with a limited demand even if they are the best (or only) effective treatment for a particular condition are less likely to continue to be produced once patent protection expires..